These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19429743)

  • 1. Re: The relationship of hepatitis antibodies and elevated liver enzymes with impaired fasting glucose and undiagnosed diabetes.
    Cox-North PP
    J Am Board Fam Med; 2009; 22(3):339. PubMed ID: 19429743
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship of hepatitis antibodies and elevated liver enzymes with impaired fasting glucose and undiagnosed diabetes.
    Mainous AG; Diaz VA; King DE; Everett CJ; Player MS
    J Am Board Fam Med; 2008; 21(6):497-503. PubMed ID: 18988716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease and OGTT.
    Uygur-Bayramiçli O; Sargin M
    J Clin Gastroenterol; 2008 Feb; 42(2):219. PubMed ID: 18209601
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C and diabetes mellitus.
    Banerjee S; Banerjee M
    J Indian Med Assoc; 2006 Feb; 104(2):86-9. PubMed ID: 16856589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease?
    Hickman IJ; Russell AJ; Prins JB; Macdonald GA
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e10-2. PubMed ID: 18187226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical markers: the road map for the diagnosis of nonalcoholic fatty liver disease.
    Ahmed MH
    Am J Clin Pathol; 2007 Jan; 127(1):20-2. PubMed ID: 17145635
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there disease progression in patients who are hepatitis C virus antibody-positive and hepatitis C virus RNA-seronegative?
    Wiesner RH
    Hepatology; 2008 Dec; 48(6):1734-6. PubMed ID: 19026008
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic approach to liver enzyme elevation.
    Craxì A; Almasio P
    J Hepatol; 1996; 25 Suppl 1():47-51. PubMed ID: 8954192
    [No Abstract]   [Full Text] [Related]  

  • 9. Community-based population data indicates the significant alterations of insulin resistance, chronic inflammation and urine ACR in IFG combined IGT group among prediabetic population.
    Lü Q; Tong N; Liu Y; Li N; Tang X; Zhao J; Cao H; Li D; Gou L; Zhang Y; Wan J; Jiang L
    Diabetes Res Clin Pract; 2009 Jun; 84(3):319-24. PubMed ID: 19442860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Dietary Patterns and Serum Hepatic Enzyme Levels in Adults with Dyslipidemia and Impaired Fasting Plasma Glucose.
    Lin LY; Hsu CY; Chiou HY; Lee HA; Hsu LM; Chang PY; Kurniawan AL; Chao JC
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33803758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease may be associated with endothelial dysfunction.
    Balta S; Demirkol S; Arslan Z; Demir M; Unlu M; Kucuk U
    Ups J Med Sci; 2014 Mar; 119(1):57. PubMed ID: 24195578
    [No Abstract]   [Full Text] [Related]  

  • 12. Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease.
    Dogru T; Sertoglu E; Celebi G; Gurel H; Ercin CN
    Ups J Med Sci; 2014 Mar; 119(1):58-9. PubMed ID: 24328674
    [No Abstract]   [Full Text] [Related]  

  • 13. Liver enzymes, metabolic syndrome, and insulin resistance.
    Kawada T
    J Diabetes; 2011 Sep; 3(3):182-3. PubMed ID: 21631900
    [No Abstract]   [Full Text] [Related]  

  • 14. Increase of incidence of impaired fasting glucose in young schizophrenia patients.
    Chiu HJ; Loh el-W; Lan TH; Sou JH; Hsieh HC; Hu TM
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):127-8. PubMed ID: 19154223
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired insulin signaling as a potential trigger of pain in diabetes and prediabetes.
    Dobretsov M; Ghaleb AH; Romanovsky D; Pablo CS; Stimers JR
    Int Anesthesiol Clin; 2007; 45(2):95-105. PubMed ID: 17426511
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelial dysfunction in patients with non-alcoholic steatohepatitis.
    Onal IK
    Ups J Med Sci; 2014 Aug; 119(3):290-1. PubMed ID: 24397312
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of endothelial dysfunction in patients with non-alcoholic steatohepatitis.
    Sarli B; Arinc H; Baktir AO; Saglam H; Demirci E
    Ups J Med Sci; 2014 Mar; 119(1):60-1. PubMed ID: 24236751
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver enzymes and cardiovascular outcomes: a new research agenda.
    Yilmaz Y; Kurt R; Kalayci C
    Hepatology; 2010 Dec; 52(6):2242. PubMed ID: 20672380
    [No Abstract]   [Full Text] [Related]  

  • 20. Gamma-glutamyltransferase activity and insulin resistance in chronic hepatitis C.
    Gentilcore E; Bugianesi E
    Dig Liver Dis; 2009 Aug; 41(8):553-4. PubMed ID: 19481509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.